Initial Experience with Humanized Allogeneic and Autologous Exosome-Based Therapies in Androgenetic Alopecia: A case series

AUTHORS

Suruchi Garg, Navnee Jain, Carol Lobo

ABSTRACT

Hair loss, particularly androgenetic alopecia (AGA) and female pattern hair loss (FPHL), is a common dermatologic concern with significant impact on the quality of life and psychosocial well-being of patients. Although current FDA approved therapies such as minoxidil, finasteride and low-level laser therapy can slow progression and promote modest regrowth, their use is often limited by poor compliance, adverse effects and need for long term use.